ATE111227T1 - Verfahren zur analyse von zellbestandteilen in einer flüssigkeit. - Google Patents

Verfahren zur analyse von zellbestandteilen in einer flüssigkeit.

Info

Publication number
ATE111227T1
ATE111227T1 AT89306036T AT89306036T ATE111227T1 AT E111227 T1 ATE111227 T1 AT E111227T1 AT 89306036 T AT89306036 T AT 89306036T AT 89306036 T AT89306036 T AT 89306036T AT E111227 T1 ATE111227 T1 AT E111227T1
Authority
AT
Austria
Prior art keywords
procedure
liquid
cell components
analyzing cell
nucleic acid
Prior art date
Application number
AT89306036T
Other languages
English (en)
Inventor
Michael R Loken
Leon W M M Terstappen
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE111227T1 publication Critical patent/ATE111227T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N2015/1006—Investigating individual particles for cytology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1402—Data analysis by thresholding or gating operations performed on the acquired signals or stored data
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Optical Measuring Cells (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AT89306036T 1988-06-15 1989-06-14 Verfahren zur analyse von zellbestandteilen in einer flüssigkeit. ATE111227T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/207,099 US5047321A (en) 1988-06-15 1988-06-15 Method for analysis of cellular components of a fluid

Publications (1)

Publication Number Publication Date
ATE111227T1 true ATE111227T1 (de) 1994-09-15

Family

ID=22769201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89306036T ATE111227T1 (de) 1988-06-15 1989-06-14 Verfahren zur analyse von zellbestandteilen in einer flüssigkeit.

Country Status (11)

Country Link
US (1) US5047321A (de)
EP (1) EP0347210B1 (de)
JP (1) JPH0726954B2 (de)
AT (1) ATE111227T1 (de)
AU (1) AU613197B2 (de)
CA (1) CA1340170C (de)
DE (1) DE68918004T2 (de)
DK (1) DK296889A (de)
ES (1) ES2063820T3 (de)
FI (1) FI94180C (de)
NO (1) NO175506C (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO164622C (no) * 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
US4963478A (en) * 1988-07-05 1990-10-16 Immucor, Inc. Article for preforming immunological assays utilizing organic dyes and method for producing and utilizing same
FR2638848B1 (fr) * 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
FR2653447B1 (fr) * 1989-10-20 1991-12-27 Bio Merieux Procede et reactifs pour la detection de micro-organismes.
DE69118429T2 (de) * 1990-01-26 1996-09-12 Canon Kk Verfahren zur Messung einer Spezies unter Verwendung von Fluoreszenzlicht
US5229265A (en) * 1990-03-13 1993-07-20 Litron Laboratories Process for analyzing clastogenic agents
US5401847A (en) * 1990-03-14 1995-03-28 Regents Of The University Of California DNA complexes with dyes designed for energy transfer as fluorescent markers
US5622853A (en) * 1990-05-01 1997-04-22 Becton Dickinson And Company T lymphocyte precursor
US5650275A (en) * 1990-06-11 1997-07-22 Nexstar Pharmacueticals Inc Target detection method using spectroscopically detectable nucleic acid ligands
US5641629A (en) * 1990-06-11 1997-06-24 Nexstar Pharmacueticals Inc Spectroscopically detectable nucleic acid ligands
IE76732B1 (en) * 1990-08-07 1997-11-05 Becton Dickinson Co One step test for absolute counts
WO1992010588A1 (en) * 1990-12-06 1992-06-25 Affymax Technologies N.V. Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
JP2927979B2 (ja) * 1991-02-22 1999-07-28 シスメックス株式会社 フローサイトメトリーによる赤芽球の分類方法
US5776709A (en) * 1991-08-28 1998-07-07 Becton Dickinson And Company Method for preparation and analysis of leukocytes in whole blood
CA2087086A1 (en) * 1992-01-22 1993-07-23 Leon Wmm Terstappen Multidimensional cell differential analysis
EP0586183B1 (de) * 1992-09-04 1999-10-13 Becton, Dickinson and Company Kontroll-Teilchen für die Zellzählung und Instrumentenlinearität
EP0608987B1 (de) * 1993-01-26 2001-10-10 Becton, Dickinson and Company Verfahren zum Nachweis von seltenen Ereignissen
US5294799A (en) * 1993-02-01 1994-03-15 Aslund Nils R D Apparatus for quantitative imaging of multiple fluorophores
DE69434942T2 (de) * 1993-02-25 2007-11-29 Abbott Laboratories, Abbott Park Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
EP0685071A4 (de) * 1993-11-12 2000-12-13 Becton Dickinson Co Verfahren zu absoluter zählung von seltenen zellen
GB9326238D0 (en) * 1993-12-23 1994-02-23 Sinvent As Method of assay
EP0684316B1 (de) * 1994-04-29 2004-10-20 Johnson & Johnson Clinical Diagnostics, Inc. Homogenes Verfahren zum Nachweis von Doppelstrang-Nukleinsäuren mittels fluoreszierender Farbstoffe und dafür nützliche Kits
US5631165A (en) * 1994-08-01 1997-05-20 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5891734A (en) * 1994-08-01 1999-04-06 Abbott Laboratories Method for performing automated analysis
US5656499A (en) * 1994-08-01 1997-08-12 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5559037A (en) * 1994-12-15 1996-09-24 Abbott Laboratories Method for rapid and simultaneous analysis of nucleated red blood cells
US5879900A (en) * 1994-12-15 1999-03-09 Abbott Laboratories Method for simultaneous analysis of cell viability, nucleated red blood cells and white blood cell differentials
US6329158B1 (en) * 1995-09-15 2001-12-11 Becton Dickinson And Company Use of dimly fluorescing nucleic acid dyes in the identification of nucleated cells
CA2240158C (en) * 1995-12-15 2004-11-30 Abbott Laboratories Method for simultaneous analysis of cell viability, nucleated red blood cells and white blood cell differential
TW438973B (en) * 1995-12-19 2001-06-07 Sysmex Corp Apparatus and method for analyzing solid components in urine
JP3308441B2 (ja) * 1995-12-19 2002-07-29 シスメックス株式会社 尿中有形成分分析装置
JP3783808B2 (ja) * 1997-05-19 2006-06-07 シスメックス株式会社 白血球分類計数用試薬
DE19756782A1 (de) * 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Nachweis und Bestimmung festphasenassoziierter Faktoren
US6911313B2 (en) * 1998-02-06 2005-06-28 Sysmex Corporation Process for discriminating and counting erythroblasts
DE19857692C1 (de) * 1998-12-14 2000-08-24 Evotec Biosystems Ag Verfahren und Vorrichtung zur zellspurbasierten Zelluntersuchung
JP3817091B2 (ja) * 1999-07-02 2006-08-30 テルモ株式会社 細胞数測定装置
JP3929283B2 (ja) * 2000-11-08 2007-06-13 シスメックス株式会社 骨髄有核細胞の分類計数方法
US6403378B1 (en) * 2001-04-26 2002-06-11 Guava Technologies, Inc. Cell viability assay reagent
GB0118995D0 (en) * 2001-08-03 2001-09-26 Univ Wales Medicine Detection of mutations in nucleic acids
WO2003016866A2 (en) * 2001-08-16 2003-02-27 Litron Laboratories Ltd Method for the enumeration of mammalian micronucleated erythrocyte populations with a single-laser flow cytometer
ES2257524T3 (es) * 2002-05-14 2006-08-01 Universidad De Salamanca Analisis multidimensional de la formula leucocitaria.
JP4299597B2 (ja) 2002-07-29 2009-07-22 シスメックス株式会社 血液分析装置及び方法
US7507548B2 (en) 2003-03-04 2009-03-24 University Of Salamanca Multidimensional detection of aberrant phenotypes in neoplastic cells to be used to monitor minimal disease levels using flow cytometry measurements
US7674598B2 (en) * 2004-05-21 2010-03-09 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential
US7625712B2 (en) 2004-05-21 2009-12-01 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential
US7321843B2 (en) * 2005-09-30 2008-01-22 Universidad De Salamanca Method for generating new flow cytometry data files containing an infinite number of dimensions based on data estimation
US8958990B2 (en) * 2005-10-03 2015-02-17 Sysmex Corporation Sample analyzer and sample analyzing method
WO2008018905A2 (en) * 2006-01-17 2008-02-14 Cellumen, Inc. Method for predicting biological systems responses
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US20100112602A1 (en) * 2006-11-10 2010-05-06 Taylor Lansing D Protein-Protein Interaction Biosensors and Methods of Use Thereof
US8137975B2 (en) * 2007-10-29 2012-03-20 Beckman Coulter, Inc. Method for a rapid antibody-based analysis of platelet populations
US8159670B2 (en) * 2007-11-05 2012-04-17 Abbott Laboratories Method and apparatus for rapidly counting and identifying biological particles in a flow stream
DE102008030515A1 (de) * 2008-06-27 2009-12-31 Christian Seliger Durchflusszytometrisches Verfahren zur Bestimmung von Gesamtleukozytenzahl und Thrombozytenzahl sowie zur Leukozytendifferenzierung in Blutproben von Vögeln
US8758287B2 (en) 2008-11-12 2014-06-24 Marv Enterprises, LLC Utilization of stents for the treatment of blood borne carcinomas
WO2010068812A1 (en) * 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
US9216386B2 (en) 2009-03-17 2015-12-22 Marv Enterprises, LLC Sequential extracorporeal treatment of bodily fluids
JP5452058B2 (ja) * 2009-03-31 2014-03-26 シスメックス株式会社 血液分析装置
EP2259065A1 (de) 2009-06-03 2010-12-08 Erasmus University Medical Center Rotterdam Verfahren, Reagenzien und Kits für die strömungszytometrische Immunphänotypisierung
JP2011092104A (ja) * 2009-10-30 2011-05-12 Hitachi Engineering & Services Co Ltd 微生物などの検査方法及び検査装置
SG174650A1 (en) * 2010-03-31 2011-10-28 Agency Science Tech & Res A method of monitoring parasite development in blood
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
ES2739623T3 (es) 2011-03-17 2020-02-03 Cernostics Inc Sistemas y composiciones para diagnosticar el esófago de Barrett y métodos para usarlos
EP3650831A1 (de) * 2011-05-04 2020-05-13 Abbott Laboratories System und verfahren zur analyse basophiler stoffe
US20150027950A1 (en) * 2012-03-27 2015-01-29 Marv Enterprises, LLC Treatment for atherosclerosis
US20150056608A1 (en) * 2012-05-21 2015-02-26 Marv Enterprises, LLC Method for Treating Infectious Diseases Using Emissive Energy
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
CN107003225B (zh) 2014-12-04 2020-08-18 贝克顿·迪金森公司 流式细胞术细胞分选系统及其使用方法
CN208443705U (zh) 2014-12-10 2019-01-29 贝克顿·迪金森公司 光学对准的集光系统和测量系统
WO2016100954A1 (en) 2014-12-19 2016-06-23 Captl Llc Flow cytometry using hydrodynamically planar flow
WO2016099538A1 (en) 2014-12-19 2016-06-23 Captl Llc Flow cytometry using hydrodynamically planar flow
EP3259574B1 (de) 2015-02-18 2024-03-27 Becton, Dickinson and Company Optische erfassungssysteme und verfahren zur verwendung davon
US9733176B2 (en) 2015-06-17 2017-08-15 Becton, Dickinson And Company Optical detector scatter cap assembly having a removable scatter bar and methods of using the same
GB201601073D0 (en) * 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
WO2017066404A1 (en) 2015-10-13 2017-04-20 Omega Biosystems Incorporated Multi-modal fluorescence imaging flow cytometry system
WO2017070315A1 (en) * 2015-10-23 2017-04-27 Geosyntec Consultants, Inc. Use of visibly detectable compounds as performance reference compounds in passive sampling devices
WO2017156034A1 (en) 2016-03-10 2017-09-14 Becton, Dickinson And Company Methods of evaluating a cellular sample for her-2/neu expression and compositions for practicing the same
BR112018068866B1 (pt) 2016-03-17 2022-11-29 Bd Biosciences Classificação de células utilizando um citômetro de fluxo de fluorescência de alto rendimento
CN109070083A (zh) 2016-04-22 2018-12-21 贝克顿迪金森公司 用于阵列产生的高密度沉积
EP4726370A2 (de) 2016-05-12 2026-04-15 BD Biosciences Fluoreszenzbildgebungs-durchflusszytometrie mit erhöhter bildauflösung
EP3513167B1 (de) 2016-09-13 2023-05-24 Becton, Dickinson and Company Durchflusszytometer mit optischer entzerrung
CN109073530B (zh) 2016-10-03 2022-04-26 贝克顿·迪金森公司 用于确定流式细胞仪中的流体流的液滴延迟的方法和系统
ES2950436T3 (es) 2016-12-14 2023-10-10 Becton Dickinson Co Métodos y composiciones para obtener una valoración de tuberculosis en un sujeto
US11320437B2 (en) 2017-02-08 2022-05-03 Becton, Dickinson And Company Dried dye reagent devices and methods for making and using the same
EP3586104B1 (de) 2017-02-27 2026-05-13 Becton, Dickinson and Company Lichtdetektionssysteme und verfahren zur verwendung davon
KR20200104399A (ko) 2018-01-23 2020-09-03 벡톤 디킨슨 앤드 컴퍼니 광 검출을 동적 차폐하기 위한 시스템 및 이를 사용하는 방법
CN119242071A (zh) 2018-03-30 2025-01-03 贝克顿·迪金森公司 含侧基发色团的水溶性聚合染料
EP3785017B1 (de) 2018-04-27 2025-09-10 Becton, Dickinson And Company Sammelsysteme für stromzytometrisch sortierte proben und verfahren zur verwendung davon
CN112449680B (zh) 2018-06-19 2024-08-09 贝克顿·迪金森公司 用于检测器阵列、系统的可变多路复用开关及其使用方法
CN113785187B (zh) 2019-03-22 2025-01-28 贝克顿·迪金森公司 使用射频多路复用激发数据对荧光成像进行光谱解混
WO2022225597A1 (en) 2021-04-23 2022-10-27 Becton, Dickinson And Company Fluid management system for an analyzer and/or sorter type flow type particle analyzer
US20250137905A1 (en) 2023-10-27 2025-05-01 Becton, Dickinson And Company Fluid Supply Systems Having a Flow Control Circuit and Single Fluidic Connection, and Methods of Use Thereof
BG113932A (bg) 2024-07-19 2026-01-30 Медицински университет – Пловдив Панели и китове от реагенти за измерване на минимална резидуална болест при детска в-клетъчна прекурсорна остра лимфобластна левкемия чрез имунофенотипизация

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826364A (en) * 1972-05-22 1974-07-30 Univ Leland Stanford Junior Particle sorting method and apparatus
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4544546A (en) * 1980-04-21 1985-10-01 Abbott Laboratories Fluorescent nucleic acid stains
US4520110A (en) * 1981-10-06 1985-05-28 The Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing a phycobiliprotein labeled ligand or receptor
CA1254134A (en) * 1984-03-28 1989-05-16 Mount Sinai School Of Medicine Of The City University Of New York Specific binding flow cytometry method
US4661913A (en) * 1984-09-11 1987-04-28 Becton, Dickinson And Company Apparatus and method for the detection and classification of articles using flow cytometry techniques
US4727020A (en) * 1985-02-25 1988-02-23 Becton, Dickinson And Company Method for analysis of subpopulations of blood cells
ZA867698B (en) * 1985-10-11 1987-07-29 Smithkline Beckman Corp Methods and reagents for performing subset analysis
CA1279008C (en) * 1985-10-11 1991-01-15 Smith Kline & French Canada Ltd. Methods and reagents for performing subset analysis
US4883867A (en) * 1985-11-01 1989-11-28 Becton, Dickinson And Company Detection of reticulocytes, RNA or DNA
US5016283A (en) * 1985-11-04 1991-05-14 Cell Analysis Systems, Inc. Methods and apparatus for immunoploidy analysis

Also Published As

Publication number Publication date
DK296889D0 (da) 1989-06-15
FI892926A0 (fi) 1989-06-14
ES2063820T3 (es) 1995-01-16
FI94180B (fi) 1995-04-13
EP0347210A2 (de) 1989-12-20
FI94180C (fi) 1995-07-25
JPH0273157A (ja) 1990-03-13
DE68918004T2 (de) 1995-01-05
CA1340170C (en) 1998-12-08
US5047321A (en) 1991-09-10
NO175506B (no) 1994-07-11
FI892926L (fi) 1989-12-16
DK296889A (da) 1989-12-16
NO892302L (no) 1989-12-18
NO175506C (no) 1994-10-19
NO892302D0 (no) 1989-06-05
JPH0726954B2 (ja) 1995-03-29
DE68918004D1 (de) 1994-10-13
EP0347210A3 (en) 1990-10-17
EP0347210B1 (de) 1994-09-07
AU613197B2 (en) 1991-07-25
AU3596189A (en) 1989-12-21

Similar Documents

Publication Publication Date Title
DE68918004D1 (de) Verfahren zur Analyse von Zellbestandteilen in einer Flüssigkeit.
DE3583414D1 (de) Bestandteil eines analytischen elements zur analyse von einem festkoerper in einer fluessigen probe.
ATE81724T1 (de) Verfahren zur analyse haematopoietischer zellen in einer probe.
AT383684B (de) Anordnung zur fluoreszenzoptischen messung von stoffkonzentrationen in einer probe
EP0106339A3 (de) Verfahren zur simultanen quantitativen Bestimmung der Zellen und Reagenz hierfür
FI883599A0 (fi) Omavarainen immunokoe-elementti
BR8108803A (pt) Processo e aparelho para determinacao quantitativa do nivel de hemoglobina em uma amostra biologica
ATE133257T1 (de) Ermittlung und quantifizierung mehrerer analyten unter verwendung von markierungstechniken
ATE297950T1 (de) Testverfahren und reagenzien zur quantifizierung von hbnp
EP0374620A3 (de) Verfahren und Mittel zur Bestimmung von Maleimidgruppen
DE69029556D1 (de) Trockenes analytisches Element zur quantitativen Analyse von in Vollblut enthaltenen Analyten
BR9300639A (pt) Particulas marcadoras para uso no ensaio de uma amostra de um fluido biologico,processo pra ensaiar uma amostra de fluido biologico,e,processo para ensaiar uma amostra de sangue
FI910822A7 (fi) Menetelmä DNA-polymeraasin määrittämiseksi kvantitatiivisesti ja siinäkäyttökelpoinen koepakkaus
ES2151494T3 (es) Metodo para la preparacion y analisis de leucocitos en sangre completa mediante la utilizacion de citometria de flujo.
ES2037659T3 (es) Metodos y reactivos para realizar analisis de subpoblaciones de particulas.
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
ATE142335T1 (de) Vorrichtung zur durchführung mehrerer gleichzeitiger messungen electrochemilumineszenter phänomene
ATE135746T1 (de) Enzymatisches verfahren zur bestimmung der analyt-konzentration
DK0790494T3 (da) Flerlaget testmiddel
ES2166996T3 (es) Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios.
FR2399663A1 (fr) Composition et procede pour determiner l'activite transferasique et proteasique
ATE43642T1 (de) Reagenzien und testsaetze zur quantitativen bestimmung einer viralen nukleinsaeure in einem biologischen mittel und verfahren zur bestimmung dieser viralen nukleinsaeure.
EP0355655A3 (de) Chlorid-Bestimmung
ES2129411T3 (es) Metodo para evaluar la adecuacion de especimenes clinicos para ensayos de hibridacion y estuche para realizar la evaluacion.
ATE57022T1 (de) Verfahren zur bestimmung von parathormon.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties